RA can affect your lifespan in various ways related to cardiovascular disease, lung disease, infection, depression, and ...
First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease ...
A private donation from Sally Cahill, USA, to researchers at Karolinska Institutet could make a new treatment for severe ...
Among patients with rheumatoid arthritis-associated interstitial lung disease, there was no significant difference in the ...
Understanding the type of arthritis, its causes, and management options is the first step toward living well with the ...
Kali Therapeutics said on Monday it has entered into a licensing agreement with French drugmaker Sanofi to ​develop the ...
The European Alliance of Associations for Rheumatology – updated its recommendations on the treatment of rheumatoid arthritis ...
The availability of TNF inhibitor biosimilars and the cost of treating ‘difficult-to-treat’ RA are making first-line TNF ...
Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.
BITS Pilani's new nanomedicine gel shows promising preclinical results for rheumatoid arthritis treatment, enhancing drug ...
Spyre Therapeutics, Inc. earns a Strong Buy on Phase 1 wins, IBD/RA pipeline catalysts, and $757M cash runway. Click for this ...
ELV001 aiming to disrupt the treatment paradigm for patients with incomplete response to standard of care (methotrexate + TNF inhibitors)Phase 2b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results